Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jupp

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
FEBS Letters|January 30, 1989
Stabilisation of cathepsin E by ATPD J Thomas, A D Richards, R A Jupp, et al.
Biological Chemistry Hoppe-Seyler|May 1, 1988
Purification and properties of cathepsin D from rat Yoshida ascites hepatoma AH-130G Bonelli, J Kay, L Tessitore, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Chronic splenomegaly in Nairobi, Kenya. I. Epidemiology, malarial antibody and immunoglobulin levelsK M De Cock, A N Hodgen, S B Lucas, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1990
Comparison of standard (non-oxygenated) vs. oxygenated St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol)D J Chambers, S Kosker, A Takahashi, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Aspartic proteinases and inhibitors for their control in health and diseaseJ Kay, R A Jupp, C G Norey, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1989
Clinical validation of St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol)D J Chambers, A Sakai, M V Braimbridge, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Substrate cleavage by HIV-1 proteinaseR A Jupp, A D Richards, L H Phylip, et al.
Journal of Virology|May 1, 1996
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic miceJ F Baskar, P P Smith, G Nilaver, et al.
The Biochemical Journal|February 1, 1990
The selectivity of statine-based inhibitors against various human aspartic proteinasesR A Jupp, B M Dunn, J W Jacobs, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Chronic splenomegaly in Nairobi, Kenya. II. Portal hypertensionK M De Cock, S Awadh, R S Raja, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
FEBS Letters|January 30, 1989
Stabilisation of cathepsin E by ATPD J Thomas, A D Richards, R A Jupp, et al.
Biological Chemistry Hoppe-Seyler|May 1, 1988
Purification and properties of cathepsin D from rat Yoshida ascites hepatoma AH-130G Bonelli, J Kay, L Tessitore, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Chronic splenomegaly in Nairobi, Kenya. I. Epidemiology, malarial antibody and immunoglobulin levelsK M De Cock, A N Hodgen, S B Lucas, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1990
Comparison of standard (non-oxygenated) vs. oxygenated St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol)D J Chambers, S Kosker, A Takahashi, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Aspartic proteinases and inhibitors for their control in health and diseaseJ Kay, R A Jupp, C G Norey, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1989
Clinical validation of St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol)D J Chambers, A Sakai, M V Braimbridge, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
Substrate cleavage by HIV-1 proteinaseR A Jupp, A D Richards, L H Phylip, et al.
Journal of Virology|May 1, 1996
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic miceJ F Baskar, P P Smith, G Nilaver, et al.
The Biochemical Journal|February 1, 1990
The selectivity of statine-based inhibitors against various human aspartic proteinasesR A Jupp, B M Dunn, J W Jacobs, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1987
Chronic splenomegaly in Nairobi, Kenya. II. Portal hypertensionK M De Cock, S Awadh, R S Raja, et al.
Pageof 4